+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pharmaceutical Import"

GCC Pharmaceutical Market Opportunity Insight 2025 - Product Thumbnail Image

GCC Pharmaceutical Market Opportunity Insight 2025

  • Report
  • January 2020
  • 300 Pages
  • Middle East
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
Prescription Drugs Markets in China - Product Thumbnail Image

Prescription Drugs Markets in China

  • Report
  • October 2024
  • 217 Pages
  • China
From
Prescription Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Prescription Drugs Industry Forecasts - China Focus

  • Report
  • October 2024
  • 93 Pages
  • China
From
Pharmaceuticals Industry Forecasts - China Focus - Product Thumbnail Image

Pharmaceuticals Industry Forecasts - China Focus

  • Report
  • February 2024
  • 106 Pages
  • China
From
From
Loading Indicator

The Pharmaceutical Import market is a sector of the pharmaceutical industry that involves the importation of drugs and other medical products from foreign countries. This market is driven by the need for access to drugs and medical products that are not available in the domestic market. Pharmaceutical imports are often used to fill gaps in the domestic market, such as when a drug is not available in the domestic market or when a drug is more cost-effective to import than to produce domestically. Pharmaceutical imports are also used to meet the needs of patients who require specialized drugs or treatments that are not available in the domestic market. The Pharmaceutical Import market is highly regulated, with stringent requirements for the importation of drugs and medical products. These regulations are designed to ensure the safety and efficacy of imported drugs and medical products. Companies in the Pharmaceutical Import market include Cipla, Sun Pharmaceuticals, Lupin, Dr. Reddy's Laboratories, and Glenmark Pharmaceuticals. Show Less Read more